There's an RSV vaccine you can take when you're pregnant that will not only protect you but also your baby.[1]#1 The drug, known as Abrysvo and recommended for pregnant women by the Centers for ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

Pfizer says Canada has selected its "Abrysvo" RSV vaccine for use in adults 60 and over for the upcoming virus season. "Abrysvo" is also approved for use in pregnant people to provide protection to ...

Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving each separately.

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

Covid-19 cases are high in many parts of the U.S. and they’re continuing to rise. These numbers come as flu season is coming ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...

"COVID cases go up and down and typically we get another surge in the winter months," said Dr. Joshua Meyerson, medical ...

Last year was the first year the United States has vaccines available to protect the public against all three major respiratory viruses – the Flu, RSV and COVID-19.